MS Speaks

Multiple Sclerosis => MS - RESEARCH AND NEWS => Topic started by: agate on May 11, 2019, 03:15:44 pm

Title: (AAN abst.) Higher efficacy therapies may have a disproportionately larger effect in younger PwMS
Post by: agate on May 11, 2019, 03:15:44 pm

Abstract of a presentation at the annual AAN conference (Philadelphia, May 4-10, 2019) entitled "Higher efficacy therapies appear to have a disproportionately larger effect in younger patients with multiple sclerosis" from researchers at the University of Colorado:


http://indexsmart.mirasmart.com/AAN2019/PDFfiles/AAN2019-004406.pdf